W Anthony Vernon - Net Worth and Insider Trading

W Anthony Vernon Net Worth

The estimated net worth of W Anthony Vernon is at least $4 Million dollars as of 2024-11-07. W Anthony Vernon is the Director of NovoCure Ltd and owns about 169,850 shares of NovoCure Ltd (NVCR) stock worth over $3 Million. W Anthony Vernon is the Director of Medivation Inc and owns about 13,664 shares of Medivation Inc (MDVN) stock worth over $1 Million. W Anthony Vernon is also the Director of Sio Gene Therapies Inc and owns about 6,742 shares of Sio Gene Therapies Inc (SIOX) stock worth over $3,223. Details can be seen in W Anthony Vernon's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that W Anthony Vernon has not made any transactions after 2024-06-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of W Anthony Vernon

To

W Anthony Vernon Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, W Anthony Vernon owns 9 companies in total, including NovoCure Ltd (NVCR) , Intersect ENT Inc (XENT) , and McCormick & Co Inc (MKC) among others .

Click here to see the complete history of W Anthony Vernon’s form 4 insider trades.

Insider Ownership Summary of W Anthony Vernon

Ticker Comapny Transaction Date Type of Owner
NVCR NovoCure Ltd 2024-06-04 director
XENT Intersect ENT Inc 2015-04-08 director
MKC McCormick & Co Inc 2019-03-15 director
LIMIT LIMIT 2017-04-17 director
LIMIT LIMIT 2017-04-12 director
LIMIT LIMIT 2016-09-28 director
LIMIT LIMIT 2009-08-17 President & Kraft Foods NA
LIMIT LIMIT 2008-05-15 director
LIMIT LIMIT 2021-02-10 director

W Anthony Vernon Latest Holdings Summary

W Anthony Vernon currently owns a total of 3 stocks. Among these stocks, W Anthony Vernon owns 169,850 shares of NovoCure Ltd (NVCR) as of June 4, 2024, with a value of $3 Million and a weighting of 72.87%. W Anthony Vernon owns 13,664 shares of Medivation Inc (MDVN) as of March 15, 2013, with a value of $1 Million and a weighting of 27.05%. W Anthony Vernon also owns 6,742 shares of Sio Gene Therapies Inc (SIOX) as of April 17, 2017, with a value of $3,223 and a weighting of 0.08%.

Latest Holdings of W Anthony Vernon

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NVCR NovoCure Ltd 2024-06-04 169,850 17.65 2,997,853
MDVN Medivation Inc 2013-03-15 13,664 81.44 1,112,796
SIOX Sio Gene Therapies Inc 2017-04-17 6,742 0.48 3,223

Holding Weightings of W Anthony Vernon


W Anthony Vernon Form 4 Trading Tracker

According to the SEC Form 4 filings, W Anthony Vernon has made a total of 1 transactions in NovoCure Ltd (NVCR) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in NovoCure Ltd is the sale of 964 shares on June 4, 2024, which brought W Anthony Vernon around $23,030.

According to the SEC Form 4 filings, W Anthony Vernon has made a total of 0 transactions in Medivation Inc (MDVN) over the past 5 years. The most-recent trade in Medivation Inc is the sale of 120,000 shares on March 15, 2013, which brought W Anthony Vernon around $3 Million.

According to the SEC Form 4 filings, W Anthony Vernon has made a total of 0 transactions in Sio Gene Therapies Inc (SIOX) over the past 5 years. The most-recent trade in Sio Gene Therapies Inc is the acquisition of 6,742 shares on April 17, 2017, which cost W Anthony Vernon around $999,992.

Insider Trading History of W Anthony Vernon

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

W Anthony Vernon Trading Performance

GuruFocus tracks the stock performance after each of W Anthony Vernon's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by W Anthony Vernon is 10.09%. GuruFocus also compares W Anthony Vernon's trading performance to market benchmark return within the same time period. The performance of stocks bought by W Anthony Vernon within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how W Anthony Vernon's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of W Anthony Vernon

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -0.42 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -0.76 LIMIT LIMIT LIMIT LIMIT LIMIT

W Anthony Vernon Ownership Network

Ownership Network List of W Anthony Vernon

No Data

Ownership Network Relation of W Anthony Vernon

Insider Network Chart

W Anthony Vernon Owned Company Details

What does NovoCure Ltd do?

Who are the key executives at NovoCure Ltd?

W Anthony Vernon is the director of NovoCure Ltd. Other key executives at NovoCure Ltd include President & CNS Cancers US Frank X Leonard , Chief Human Resources Officer Michal Nath Puri , and Chief Financial Officer Ashley Cordova .

NovoCure Ltd (NVCR) Insider Trades Summary

Over the past 18 months, W Anthony Vernon made 1 insider transaction in NovoCure Ltd (NVCR) with a net sale of 964. Other recent insider transactions involving NovoCure Ltd (NVCR) include a net sale of 5,921 shares made by Wilhelmus Cm Groenhuysen , a net sale of 5,195 shares made by Frank X Leonard , and a net sale of 2,715 shares made by Ashley Cordova .

In summary, during the past 3 months, insiders sold 1,612 shares of NovoCure Ltd (NVCR) in total and bought 0 shares, with a net sale of 1,612 shares. During the past 18 months, 18,392 shares of NovoCure Ltd (NVCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 18,392 shares.

NovoCure Ltd (NVCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

NovoCure Ltd Insider Transactions

No Available Data

W Anthony Vernon Mailing Address

Above is the net worth, insider trading, and ownership report for W Anthony Vernon. You might contact W Anthony Vernon via mailing address: C/o Axovant Sciences, Inc., 320 West 37th Street, New York Ny 10018.